Navigation Links
Schering-Plough Reports Financial Results for Third Quarter of 2008
Date:10/21/2008

n Agenda and anticipated timing regarding future performance of the Action Agenda; business prospects; anticipated growth; timing and level of savings achieved from the Productivity Transformation Program, including the ongoing integration of OBS; prospective products or product approvals; trends in performance; anticipated timing of clinical trials and its impact on R&D spending; anticipated exclusivity periods; actions to enhance clinical, R&D, manufacturing and post-marketing systems; and the potential of products and trending in therapeutic markets, including the cholesterol market. Actual results may vary materially from the company's forward-looking statements, and there are no guarantees about the performance of Schering-Plough stock or Schering-Plough's business. Schering-Plough does not assume the obligation to update any forward-looking statement. A number of risks and uncertainties could cause results to differ materially from forward-looking statements, including, among other uncertainties, market viability of the company's (and the cholesterol joint venture's) marketed and pipeline products; market forces; economic factors such as interest rate and exchange rate fluctuations; the outcome of contingencies such as litigation and investigations including litigation and investigations relating to the ENHANCE clinical trial; product availability; patent and other intellectual property protection; current and future branded, generic or over-the-counter competition; the regulatory process (including product approvals, labeling and post-marketing actions); scientific developments relating to marketed products or pipeline projects; and media and societal reaction to such developments. For further details of these and other risks and uncertainties that may impact forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Item 8.01 of the company's 8-K filed today.

Schering-Plough is an innovation-driven, science
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine news :

1. Schering-Plough Announces Transition of Animal Health Leadership
2. Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture
3. Hagens Berman Appointed Co-Lead Counsel in Case Against Schering-Plough and Merck
4. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
5. Bayer/Schering-Plough/Shionogis Avelox Has Advantages Over Levofloxacin in the Treatment of Community-Acquired Pneumonia
6. Schering-Plough Announces Expanded Stock Retention Guidelines for Senior Management
7. Schering-Plough to Webcast Presentation by CEO Fred Hassan at Lehman Brothers Eleventh Annual Global Healthcare Conference
8. Schering-Plough Promotes Ian Mcinnes to President of Global Supply Chain
9. CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough
10. Lawsuit Filed in Florida Federal Court Over Marketing of Vytorin and Zetia By Merck and Schering-Plough
11. Schering-Plough CEO to Buy $2 Million in Common Shares
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 2014 TMG Health, the leading ... health plans in the Medicare Advantage, Medicare Part ... held its annual Client Forum at its National ... theme, “Partners in Excellence: Navigating the Post-Reform Landscape ... leaders from TMG Health’s Client base of Health ...
(Date:7/29/2014)... Kathleen Doheny HealthDay Reporter ... at low risk of cardiovascular disease may be able to ... time without harming their hearts, according to a new study. ... that hormone replacement therapy had harmful effects on the heart. ... the hormone treatments, and much further past menopause. ...
(Date:7/29/2014)... , assistant professors at the Virginia Tech Carilion ... Commonwealth Health Research Board to investigate hereditary ... treatment approaches. , The board funds research intended to ... two-year project to study the mechanisms behind hereditary breast ... cancer often has a poor outcome, especially in Virginians ...
(Date:7/29/2014)... July 29, 2014 The global market ... million by 2020, growing at an estimated CAGR of ... study by Grand View Research, Inc. Introduction of technological ... by the geriatric population, along with increase in demand ... major drivers of this market. In addition, presence of ...
(Date:7/29/2014)... On Friday, the United States Senate introduced ... October 12-18, 2014, as "National Case Management Week" to ... outcomes for patients. The resolution was introduced by Senator ... support by the Case Management Society of America and ... professionals for their contributions to healthcare. , “Case managers ...
Breaking Medicine News(10 mins):Health News:TMG Health Client Forum Explores Strategies for Success in the Post-Reform Market 2Health News:TMG Health Client Forum Explores Strategies for Success in the Post-Reform Market 3Health News:Early Hormone Therapy May Be Safe for Women's Hearts 2Health News:Early Hormone Therapy May Be Safe for Women's Hearts 3Health News:Scientists to study hereditary breast cancer to find BRCA1 treatment 2Health News:Audiology Devices Market Analysis by Product (Cochlear Implants, Bone Anchored Hearing Aids, Hearing Aids, Audiometers) Expected to Reach USD 9,542.3 Million by 2020 2Health News:Audiology Devices Market Analysis by Product (Cochlear Implants, Bone Anchored Hearing Aids, Hearing Aids, Audiometers) Expected to Reach USD 9,542.3 Million by 2020 3Health News:Audiology Devices Market Analysis by Product (Cochlear Implants, Bone Anchored Hearing Aids, Hearing Aids, Audiometers) Expected to Reach USD 9,542.3 Million by 2020 4Health News:Audiology Devices Market Analysis by Product (Cochlear Implants, Bone Anchored Hearing Aids, Hearing Aids, Audiometers) Expected to Reach USD 9,542.3 Million by 2020 5Health News:Audiology Devices Market Analysis by Product (Cochlear Implants, Bone Anchored Hearing Aids, Hearing Aids, Audiometers) Expected to Reach USD 9,542.3 Million by 2020 6Health News:CMSA Supports National Case Management Week Resolution Introduced in US Senate 2
... More than 125 leaders,from throughout the state ... to support a multi-year, statewide campaign to Make ... launched by Nemours Health,and Prevention Services (NHPS), will ... professionals, parents, and other leaders to,improve the motivation, ...
... Oct. 1 The Coalition to,Protect Florida,s Drivers ... thanked him for expanding the call of this ... expired at midnight,today. Saying that Personal Injury ... of Florida" and that $10,000 in PIP coverage,provides ...
... Bally Total Fitness announced,that it has successfully ... company,just over two months after filing for bankruptcy ... by Harbinger Capital Partners,Master Fund I, Ltd. and ... effective today. Harbinger invested approximately $233.6 million ...
... WASHINGTON, Oct. 1 The following is being,issued by ... Emmanuel Cleaver, D-Missouri Congresswoman Heather Wilson, R- New Mexico ... author of God,s Politics, Others Participating: ... national Catholic Social Justice Lobby Father ...
... public entities in the addiction treatment field announced the ... Now (ACTION) Campaign for the improvement of addiction treatment ... to addiction treatment for individuals in need and to ... launched during National Recovery Month in September, has a ...
... Oct. 1 Air Methods Corporation,(Nasdaq: AIRM ), ... today that the Company has completed its acquisition of,100% ... (parent,company of CJ Systems Aviation Group, Inc., or "CJ") ... today at 12:01 a.m. The final cash purchase ...
Cached Medicine News:Health News:More than 125 State Leaders - Including Governor, Lt. Governor, and Congressional Delegation - Endorse Campaign to Make Delaware's Kids the Healthiest in the Nation 2Health News:More than 125 State Leaders - Including Governor, Lt. Governor, and Congressional Delegation - Endorse Campaign to Make Delaware's Kids the Healthiest in the Nation 3Health News:Coalition to Protect Florida's Drivers Applauds Governor Crist for Adding PIP to Special Session 2Health News:Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds 2Health News:Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds 3Health News:Leaders in addiction treatment announce national 'ACTION' campaign 2Health News:Air Methods Completes Acquisition of FSS Airholdings, Inc., Parent Company of CJ Systems Aviation Group, Inc. 2
(Date:7/29/2014)... 2014  The Healthcare Analytics Summit 2014 ... Salt Lake City , Sept. 24-25 has ... healthcare organizations in the U.S. and beyond.  HAS ,14, ... conference devoted to providing immersive learning experiences on ... both accountable care initiatives and population health managemen ...
(Date:7/29/2014)... IRVING, Texas , July 29, 2014 /PRNewswire/ ... three new web-based applications with breakthrough interactive features ... and workflows for members of Children,s Hospital Association.  ... under the Novation Optimize Solutions umbrella – Value ... of how Novation helps organizations address the most ...
(Date:7/29/2014)... July 29, 2014   Abide Therapeutics ... to its board of directors. Thornberry was ... and Endocrinology for Merck & Co. Inc., where ... pipeline management in diabetes, osteoporosis, fertility and contraception. ... the program that resulted in the discovery of ...
Breaking Medicine Technology:Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 2Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 3Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 4Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 5Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 2Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 3Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 4Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 5Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 2Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 3
... Bayer HealthCare Pharmaceuticals was handed a pounding $100 ... unlikely to relieve.  The law firm of Sanford Wittels ... U.S. District Court for New Jersey, citing instances of ... employees at Novartis Pharmaceuticals who successfully won a jury ...
... 2011 Beginning April 1, Highmark Blue Cross Blue ... patients with primary immunodeficiency diseases and other rare disorders ... immunoglobulin (IgG - a blood plasma product), regardless of ... even patients who are being treated successfully with another ...
Cached Medicine Technology:Bayer Gets $100M Gender Class Action Headache 2Bayer Gets $100M Gender Class Action Headache 3Bayer Gets $100M Gender Class Action Headache 4Despite New Changes, Highmark Policy Still Threatens Patients With Primary Immunodeficiency Diseases 2Despite New Changes, Highmark Policy Still Threatens Patients With Primary Immunodeficiency Diseases 3
... 2 gel holder cassettes, 4 fiber pads, ... buffer chamber, lid with cables, and instructions. ... of Bio-Rad's modular mini electrophoresis system (see ... of mini gels. Its modular electrode assembly ...
... 200 power supply. Flexibility ... Quantitative Transfers. Native Enzyme, ... Faster, Higher-Efficiency Transfers via ... Transfers with Movable Electrodes. ...
... gel holder cassettes, cell with ... pads, blot absorbent paper (15 ... transfer cell, used with the ... efficient, high-intensity electrophoretic transfers. The ...
... for running Criterion precast gels and ... blotter fit for use with the ... the Criterion blotter combines excellent blotting ... Trans-Blot system and the ease-of-use of ...
Medicine Products: